Rafferty Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,333,278
| Closed | -$3.61M | – | 1350 |
|
|
2021
Q4 | $3.61M | Buy |
1,333,278
+618,590
| +87% | +$1.68M | 0.02% | 494 |
|
|
2021
Q3 | $3.19M | Buy |
714,688
+263,392
| +58% | +$1.17M | 0.02% | 443 |
|
|
2021
Q2 | $2.62M | Sell |
451,296
-109,628
| -20% | -$636K | 0.02% | 569 |
|
|
2021
Q1 | $3.94M | Buy |
560,924
+368,716
| +192% | +$2.59M | 0.03% | 348 |
|
|
2020
Q4 | $923K | Sell |
192,208
-136,295
| -41% | -$655K | 0.01% | 526 |
|
|
2020
Q3 | $1.92M | Buy |
328,503
+187,227
| +133% | +$1.09M | 0.02% | 427 |
|
|
2020
Q2 | $954K | Buy |
141,276
+124,431
| +739% | +$840K | 0.01% | 561 |
|
|
2020
Q1 | $107K | Sell |
16,845
-126,265
| -88% | -$802K | ﹤0.01% | 555 |
|
|
2019
Q4 | $1.49M | Buy |
+143,110
| New | +$1.49M | 0.02% | 456 |
|
|
2019
Q3 | – | Sell |
-367,079
| Closed | -$5.46M | – | 866 |
|
|
2019
Q2 | $5.46M | Buy |
367,079
+186,542
| +103% | +$2.77M | 0.1% | 143 |
|
|
2019
Q1 | $4.48M | Buy |
+180,537
| New | +$4.48M | 0.07% | 156 |
|